Magnesium in PDB 4cyp: Leishmania Major N-Myristoyltransferase in Complex with A Pyrrolidine Inhibitor.

Enzymatic activity of Leishmania Major N-Myristoyltransferase in Complex with A Pyrrolidine Inhibitor.

All present enzymatic activity of Leishmania Major N-Myristoyltransferase in Complex with A Pyrrolidine Inhibitor.:
2.3.1.97;

Protein crystallography data

The structure of Leishmania Major N-Myristoyltransferase in Complex with A Pyrrolidine Inhibitor., PDB code: 4cyp was solved by J.A.Hutton, V.Goncalves, J.A.Brannigan, D.Paape, T.Waugh, S.M.Roberts, A.S.Bell, A.J.Wilkinson, D.F.Smith, R.J.Leatherbarrow, E.W.Tate, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

*Resolution Low / High (Å)*	49.47 / 1.55
*Space group*	P 1 2₁ 1
*Cell size a, b, c (Å), α, β, γ (°)*	48.262, 92.494, 53.717, 90.00, 112.93, 90.00
*R / R_free (%)*	20.499 / 25.24

Other elements in 4cyp:

The structure of Leishmania Major N-Myristoyltransferase in Complex with A Pyrrolidine Inhibitor. also contains other interesting chemical elements:

Chlorine

(Cl)

2 atoms

Magnesium Binding Sites:

The binding sites of Magnesium atom in the Leishmania Major N-Myristoyltransferase in Complex with A Pyrrolidine Inhibitor. (pdb code 4cyp). This binding sites where shown within 5.0 Angstroms radius around Magnesium atom.
In total only one binding site of Magnesium was determined in the Leishmania Major N-Myristoyltransferase in Complex with A Pyrrolidine Inhibitor., PDB code: 4cyp:

Magnesium binding site 1 out of 1 in 4cyp

Go back to

Magnesium Binding Sites List in 4cyp

Magnesium binding site 1 out of 1 in the Leishmania Major N-Myristoyltransferase in Complex with A Pyrrolidine Inhibitor.

Mono view

Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 1 of Leishmania Major N-Myristoyltransferase in Complex with A Pyrrolidine Inhibitor. within 5.0Å range:

probe	atom	residue	distance (Å)	B	Occ
A:Mg999 b:28.3 occ:1.00	O2A	A:MYA1001	2.8	20.6	1.0
	O	A:LEU175	2.8	22.8	1.0
	N	A:LYS178	2.8	21.8	1.0
	O4A	A:MYA1001	3.0	17.8	1.0
	N	A:LEU180	3.1	23.2	1.0
	N	A:ARG179	3.2	24.2	1.0
	CB	A:LEU180	3.4	22.6	1.0
	N	A:GLU177	3.4	24.6	1.0
	CA	A:LYS178	3.5	23.5	1.0
	C	A:LYS178	3.5	22.8	1.0
	P1A	A:MYA1001	3.6	20.9	1.0
	CB	A:LYS178	3.7	23.6	1.0
	O1A	A:MYA1001	3.7	20.4	1.0
	CA	A:LEU180	3.8	20.9	1.0
	C	A:ARG176	3.8	24.8	1.0
	C	A:GLU177	3.9	26.3	1.0
	C	A:LEU175	3.9	22.4	1.0
	CA	A:GLU177	4.0	26.1	0.5
	CA	A:GLU177	4.0	25.2	0.5
	CA	A:ARG176	4.1	21.9	1.0
	C	A:ARG179	4.1	22.9	1.0
	CG1	A:VAL171	4.1	17.2	1.0
	P2A	A:MYA1001	4.1	19.0	1.0
	CA	A:ARG179	4.2	22.6	1.0
	O	A:LYS178	4.3	28.1	1.0
	O3A	A:MYA1001	4.3	19.1	1.0
	N	A:ALA181	4.3	20.1	1.0
	N	A:ARG176	4.5	23.2	1.0
	CG	A:LYS178	4.6	28.3	1.0
	C	A:LEU180	4.6	22.2	1.0
	O	A:ARG176	4.6	27.9	1.0
	O6A	A:MYA1001	4.7	18.4	1.0
	CG	A:LEU180	4.8	23.4	1.0
	CG2	A:VAL171	4.8	19.3	1.0
	CB	A:VAL171	4.9	16.4	1.0
	O	A:GLU177	5.0	28.4	1.0

Reference:

A.Hutton, V.Goncalves, J.A.Brannigan, D.Paape, M.H.Wright, T.M.Waugh, S.M.Roberts, A.S.Bell, A.J.Wilkinson, D.F.Smith, R.J.Leatherbarrow, E.W.Tate. Structure-Based Design of Potent and Selective Leishmania N- Myristoyltransferase Inhibitors. J.Med.Chem. V. 57 8664 2014.
ISSN: ISSN 0022-2623
PubMed: 25238611
DOI: 10.1021/JM5011397

Page generated: Thu Aug 15 16:55:51 2024

Last articles

Zn in 9J0N
Zn in 9J0O
Zn in 9J0P
Zn in 9FJX
Zn in 9EKB
Zn in 9C0F
Zn in 9CAH
Zn in 9CH0
Zn in 9CH3
Zn in 9CH1

	© Copyright 2008-2020 by atomistry.com
Home \| Site Map \| Copyright \| Contact us \| Privacy